Global Blood-based Cancer Screening Tests Market Growth (Status and Outlook) 2026-2032
The global Blood-based Cancer Screening Tests market size is predicted to grow from US$ 4414 million in 2025 to US$ 16251 million in 2032; it is expected to grow at a CAGR of 20.9% from 2026 to 2032.
Blood-based cancer screening tests use peripheral blood signals such as circulating free DNA, circulating tumor DNA, methylation patterns, protein biomarkers, fragmentomics or multi-omics features to identify early cancer risk in asymptomatic or high-risk populations. These tests may target a single cancer type or multiple cancers and emphasize minimally invasive sampling, adherence, early detection capability, management pathways for positive and negative results and clinical validation evidence. They are commonly used in health check-ups, hospital screening, public health programs and high-risk population follow-up. The average gross profit margin of this product is 55%.
The blood-based cancer screening market is being driven by demand for early cancer detection, upgrades to colorectal cancer screening tools and accumulating clinical evidence for multi-cancer early detection. Blood sampling offers high adherence and is suitable for health check-up centers, hospital outpatient settings and high-risk population management.
Major technical routes include cfDNA methylation, multi-omics modeling, ctDNA mutation detection and protein marker combinations. Key competitive factors are early-stage sensitivity, specificity, tissue-of-origin capability, validation cohort size and cost control. Blood-based colorectal cancer tests have one of the clearest commercialization paths, while multi-cancer early detection still requires more real-world evidence.
Market adoption is affected by regulatory approval, inclusion in clinical guidelines, payment systems and the cost of managing false positives. Future growth will depend on results from large prospective studies, reimbursement by public or commercial payers, lower testing costs and clear positioning alongside established screening pathways.
LPI (LP Information)' newest research report, the ?Blood-based Cancer Screening Tests Industry Forecast? looks at past sales and reviews total world Blood-based Cancer Screening Tests sales in 2025, providing a comprehensive analysis by region and market sector of projected Blood-based Cancer Screening Tests sales for 2026 through 2032. With Blood-based Cancer Screening Tests sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood-based Cancer Screening Tests industry.
This Insight Report provides a comprehensive analysis of the global Blood-based Cancer Screening Tests landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Blood-based Cancer Screening Tests portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Blood-based Cancer Screening Tests market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood-based Cancer Screening Tests and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood-based Cancer Screening Tests.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood-based Cancer Screening Tests market by product type, application, key players and key regions and countries.
Segmentation by Type:
Blood-based cancer screening tests use peripheral blood signals such as circulating free DNA, circulating tumor DNA, methylation patterns, protein biomarkers, fragmentomics or multi-omics features to identify early cancer risk in asymptomatic or high-risk populations. These tests may target a single cancer type or multiple cancers and emphasize minimally invasive sampling, adherence, early detection capability, management pathways for positive and negative results and clinical validation evidence. They are commonly used in health check-ups, hospital screening, public health programs and high-risk population follow-up. The average gross profit margin of this product is 55%.
The blood-based cancer screening market is being driven by demand for early cancer detection, upgrades to colorectal cancer screening tools and accumulating clinical evidence for multi-cancer early detection. Blood sampling offers high adherence and is suitable for health check-up centers, hospital outpatient settings and high-risk population management.
Major technical routes include cfDNA methylation, multi-omics modeling, ctDNA mutation detection and protein marker combinations. Key competitive factors are early-stage sensitivity, specificity, tissue-of-origin capability, validation cohort size and cost control. Blood-based colorectal cancer tests have one of the clearest commercialization paths, while multi-cancer early detection still requires more real-world evidence.
Market adoption is affected by regulatory approval, inclusion in clinical guidelines, payment systems and the cost of managing false positives. Future growth will depend on results from large prospective studies, reimbursement by public or commercial payers, lower testing costs and clear positioning alongside established screening pathways.
LPI (LP Information)' newest research report, the ?Blood-based Cancer Screening Tests Industry Forecast? looks at past sales and reviews total world Blood-based Cancer Screening Tests sales in 2025, providing a comprehensive analysis by region and market sector of projected Blood-based Cancer Screening Tests sales for 2026 through 2032. With Blood-based Cancer Screening Tests sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood-based Cancer Screening Tests industry.
This Insight Report provides a comprehensive analysis of the global Blood-based Cancer Screening Tests landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Blood-based Cancer Screening Tests portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Blood-based Cancer Screening Tests market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood-based Cancer Screening Tests and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood-based Cancer Screening Tests.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood-based Cancer Screening Tests market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Single-cancer Screening
- Multi-cancer Early Detection
- Colorectal Cancer Screening
- Liver Cancer Screening
- Lung Cancer Screening
- Risk Stratification Test
- Other
- cfDNA Methylation
- ctDNA Mutation
- Fragmentomics
- Protein Biomarkers
- Multi-omics
- Exosome-based
- Other
- Laboratory-developed Test
- IVD Kit
- Sequencing-based
- PCR-based
- Immunoassay-based
- Other
- Health Check-up Centers
- Hospitals
- Independent Clinical Laboratories
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GRAIL
- Guardant Health
- Exact Sciences
- Freenome
- Natera
- Foresight Diagnostics
- Burning Rock Biotech
- Genetron Health
- Singlera Genomics
- Berry Oncology
- Helio Genomics
- Sysmex
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Blood-based Cancer Screening Tests Market Size (2021-2032)
2.1.2 Blood-based Cancer Screening Tests Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Blood-based Cancer Screening Tests by Country/Region (2021, 2025 & 2032)
2.2 Blood-based Cancer Screening Tests Segment by Type
2.2.1 Single-cancer Screening
2.2.2 Multi-cancer Early Detection
2.2.3 Colorectal Cancer Screening
2.2.4 Liver Cancer Screening
2.2.5 Lung Cancer Screening
2.2.6 Risk Stratification Test
2.2.7 Other
2.2.8 Blood-based Cancer Screening Tests Market Size by Type
2.2.8.1 Blood-based Cancer Screening Tests Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.8.2 Global Blood-based Cancer Screening Tests Market Size Market Share by Type (2021-2026)
2.3 Blood-based Cancer Screening Tests Segment by Biomarker
2.3.1 cfDNA Methylation
2.3.2 ctDNA Mutation
2.3.3 Fragmentomics
2.3.4 Protein Biomarkers
2.3.5 Multi-omics
2.3.6 Exosome-based
2.3.7 Other
2.3.8 Blood-based Cancer Screening Tests Market Size by Biomarker
2.3.8.1 Blood-based Cancer Screening Tests Market Size CAGR by Biomarker (2021 VS 2025 VS 2032)
2.3.8.2 Global Blood-based Cancer Screening Tests Market Size Market Share by Biomarker (2021-2026)
2.4 Blood-based Cancer Screening Tests Segment by Test Format
2.4.1 Laboratory-developed Test
2.4.2 IVD Kit
2.4.3 Sequencing-based
2.4.4 PCR-based
2.4.5 Immunoassay-based
2.4.6 Other
2.4.7 Blood-based Cancer Screening Tests Market Size by Test Format
2.4.7.1 Blood-based Cancer Screening Tests Market Size CAGR by Test Format (2021 VS 2025 VS 2032)
2.4.7.2 Global Blood-based Cancer Screening Tests Market Size Market Share by Test Format (2021-2026)
2.5 Blood-based Cancer Screening Tests Segment by Application
2.5.1 Health Check-up Centers
2.5.2 Hospitals
2.5.3 Independent Clinical Laboratories
2.5.4 Other
2.5.5 Blood-based Cancer Screening Tests Market Size by Application
2.5.5.1 Blood-based Cancer Screening Tests Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.5.2 Global Blood-based Cancer Screening Tests Market Size Market Share by Application (2021-2026)
3 BLOOD-BASED CANCER SCREENING TESTS MARKET SIZE BY PLAYER
3.1 Blood-based Cancer Screening Tests Market Size Market Share by Player
3.1.1 Global Blood-based Cancer Screening Tests Revenue by Player (2021-2026)
3.1.2 Global Blood-based Cancer Screening Tests Revenue Market Share by Player (2021-2026)
3.2 Global Blood-based Cancer Screening Tests Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BLOOD-BASED CANCER SCREENING TESTS BY REGION
4.1 Blood-based Cancer Screening Tests Market Size by Region (2021-2026)
4.2 Global Blood-based Cancer Screening Tests Annual Revenue by Country/Region (2021-2026)
4.3 Americas Blood-based Cancer Screening Tests Market Size Growth (2021-2026)
4.4 APAC Blood-based Cancer Screening Tests Market Size Growth (2021-2026)
4.5 Europe Blood-based Cancer Screening Tests Market Size Growth (2021-2026)
4.6 Middle East & Africa Blood-based Cancer Screening Tests Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Blood-based Cancer Screening Tests Market Size by Country (2021-2026)
5.2 Americas Blood-based Cancer Screening Tests Market Size by Type (2021-2026)
5.3 Americas Blood-based Cancer Screening Tests Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blood-based Cancer Screening Tests Market Size by Region (2021-2026)
6.2 APAC Blood-based Cancer Screening Tests Market Size by Type (2021-2026)
6.3 APAC Blood-based Cancer Screening Tests Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Blood-based Cancer Screening Tests Market Size by Country (2021-2026)
7.2 Europe Blood-based Cancer Screening Tests Market Size by Type (2021-2026)
7.3 Europe Blood-based Cancer Screening Tests Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Blood-based Cancer Screening Tests by Region (2021-2026)
8.2 Middle East & Africa Blood-based Cancer Screening Tests Market Size by Type (2021-2026)
8.3 Middle East & Africa Blood-based Cancer Screening Tests Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BLOOD-BASED CANCER SCREENING TESTS MARKET FORECAST
10.1 Global Blood-based Cancer Screening Tests Forecast by Region (2027-2032)
10.1.1 Global Blood-based Cancer Screening Tests Forecast by Region (2027-2032)
10.1.2 Americas Blood-based Cancer Screening Tests Forecast
10.1.3 APAC Blood-based Cancer Screening Tests Forecast
10.1.4 Europe Blood-based Cancer Screening Tests Forecast
10.1.5 Middle East & Africa Blood-based Cancer Screening Tests Forecast
10.2 Americas Blood-based Cancer Screening Tests Forecast by Country (2027-2032)
10.2.1 United States Market Blood-based Cancer Screening Tests Forecast
10.2.2 Canada Market Blood-based Cancer Screening Tests Forecast
10.2.3 Mexico Market Blood-based Cancer Screening Tests Forecast
10.2.4 Brazil Market Blood-based Cancer Screening Tests Forecast
10.3 APAC Blood-based Cancer Screening Tests Forecast by Region (2027-2032)
10.3.1 China Blood-based Cancer Screening Tests Market Forecast
10.3.2 Japan Market Blood-based Cancer Screening Tests Forecast
10.3.3 Korea Market Blood-based Cancer Screening Tests Forecast
10.3.4 Southeast Asia Market Blood-based Cancer Screening Tests Forecast
10.3.5 India Market Blood-based Cancer Screening Tests Forecast
10.3.6 Australia Market Blood-based Cancer Screening Tests Forecast
10.4 Europe Blood-based Cancer Screening Tests Forecast by Country (2027-2032)
10.4.1 Germany Market Blood-based Cancer Screening Tests Forecast
10.4.2 France Market Blood-based Cancer Screening Tests Forecast
10.4.3 UK Market Blood-based Cancer Screening Tests Forecast
10.4.4 Italy Market Blood-based Cancer Screening Tests Forecast
10.4.5 Russia Market Blood-based Cancer Screening Tests Forecast
10.5 Middle East & Africa Blood-based Cancer Screening Tests Forecast by Region (2027-2032)
10.5.1 Egypt Market Blood-based Cancer Screening Tests Forecast
10.5.2 South Africa Market Blood-based Cancer Screening Tests Forecast
10.5.3 Israel Market Blood-based Cancer Screening Tests Forecast
10.5.4 Turkey Market Blood-based Cancer Screening Tests Forecast
10.6 Global Blood-based Cancer Screening Tests Forecast by Type (2027-2032)
10.7 Global Blood-based Cancer Screening Tests Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Blood-based Cancer Screening Tests Forecast
11 KEY PLAYERS ANALYSIS
11.1 GRAIL
11.1.1 GRAIL Company Information
11.1.2 GRAIL Blood-based Cancer Screening Tests Product Offered
11.1.3 GRAIL Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 GRAIL Main Business Overview
11.1.5 GRAIL Latest Developments
11.2 Guardant Health
11.2.1 Guardant Health Company Information
11.2.2 Guardant Health Blood-based Cancer Screening Tests Product Offered
11.2.3 Guardant Health Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Guardant Health Main Business Overview
11.2.5 Guardant Health Latest Developments
11.3 Exact Sciences
11.3.1 Exact Sciences Company Information
11.3.2 Exact Sciences Blood-based Cancer Screening Tests Product Offered
11.3.3 Exact Sciences Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Exact Sciences Main Business Overview
11.3.5 Exact Sciences Latest Developments
11.4 Freenome
11.4.1 Freenome Company Information
11.4.2 Freenome Blood-based Cancer Screening Tests Product Offered
11.4.3 Freenome Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Freenome Main Business Overview
11.4.5 Freenome Latest Developments
11.5 Natera
11.5.1 Natera Company Information
11.5.2 Natera Blood-based Cancer Screening Tests Product Offered
11.5.3 Natera Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Natera Main Business Overview
11.5.5 Natera Latest Developments
11.6 Foresight Diagnostics
11.6.1 Foresight Diagnostics Company Information
11.6.2 Foresight Diagnostics Blood-based Cancer Screening Tests Product Offered
11.6.3 Foresight Diagnostics Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Foresight Diagnostics Main Business Overview
11.6.5 Foresight Diagnostics Latest Developments
11.7 Burning Rock Biotech
11.7.1 Burning Rock Biotech Company Information
11.7.2 Burning Rock Biotech Blood-based Cancer Screening Tests Product Offered
11.7.3 Burning Rock Biotech Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Burning Rock Biotech Main Business Overview
11.7.5 Burning Rock Biotech Latest Developments
11.8 Genetron Health
11.8.1 Genetron Health Company Information
11.8.2 Genetron Health Blood-based Cancer Screening Tests Product Offered
11.8.3 Genetron Health Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Genetron Health Main Business Overview
11.8.5 Genetron Health Latest Developments
11.9 Singlera Genomics
11.9.1 Singlera Genomics Company Information
11.9.2 Singlera Genomics Blood-based Cancer Screening Tests Product Offered
11.9.3 Singlera Genomics Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Singlera Genomics Main Business Overview
11.9.5 Singlera Genomics Latest Developments
11.10 Berry Oncology
11.10.1 Berry Oncology Company Information
11.10.2 Berry Oncology Blood-based Cancer Screening Tests Product Offered
11.10.3 Berry Oncology Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Berry Oncology Main Business Overview
11.10.5 Berry Oncology Latest Developments
11.11 Helio Genomics
11.11.1 Helio Genomics Company Information
11.11.2 Helio Genomics Blood-based Cancer Screening Tests Product Offered
11.11.3 Helio Genomics Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Helio Genomics Main Business Overview
11.11.5 Helio Genomics Latest Developments
11.12 Sysmex
11.12.1 Sysmex Company Information
11.12.2 Sysmex Blood-based Cancer Screening Tests Product Offered
11.12.3 Sysmex Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Sysmex Main Business Overview
11.12.5 Sysmex Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Blood-based Cancer Screening Tests Market Size (2021-2032)
2.1.2 Blood-based Cancer Screening Tests Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Blood-based Cancer Screening Tests by Country/Region (2021, 2025 & 2032)
2.2 Blood-based Cancer Screening Tests Segment by Type
2.2.1 Single-cancer Screening
2.2.2 Multi-cancer Early Detection
2.2.3 Colorectal Cancer Screening
2.2.4 Liver Cancer Screening
2.2.5 Lung Cancer Screening
2.2.6 Risk Stratification Test
2.2.7 Other
2.2.8 Blood-based Cancer Screening Tests Market Size by Type
2.2.8.1 Blood-based Cancer Screening Tests Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.8.2 Global Blood-based Cancer Screening Tests Market Size Market Share by Type (2021-2026)
2.3 Blood-based Cancer Screening Tests Segment by Biomarker
2.3.1 cfDNA Methylation
2.3.2 ctDNA Mutation
2.3.3 Fragmentomics
2.3.4 Protein Biomarkers
2.3.5 Multi-omics
2.3.6 Exosome-based
2.3.7 Other
2.3.8 Blood-based Cancer Screening Tests Market Size by Biomarker
2.3.8.1 Blood-based Cancer Screening Tests Market Size CAGR by Biomarker (2021 VS 2025 VS 2032)
2.3.8.2 Global Blood-based Cancer Screening Tests Market Size Market Share by Biomarker (2021-2026)
2.4 Blood-based Cancer Screening Tests Segment by Test Format
2.4.1 Laboratory-developed Test
2.4.2 IVD Kit
2.4.3 Sequencing-based
2.4.4 PCR-based
2.4.5 Immunoassay-based
2.4.6 Other
2.4.7 Blood-based Cancer Screening Tests Market Size by Test Format
2.4.7.1 Blood-based Cancer Screening Tests Market Size CAGR by Test Format (2021 VS 2025 VS 2032)
2.4.7.2 Global Blood-based Cancer Screening Tests Market Size Market Share by Test Format (2021-2026)
2.5 Blood-based Cancer Screening Tests Segment by Application
2.5.1 Health Check-up Centers
2.5.2 Hospitals
2.5.3 Independent Clinical Laboratories
2.5.4 Other
2.5.5 Blood-based Cancer Screening Tests Market Size by Application
2.5.5.1 Blood-based Cancer Screening Tests Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.5.2 Global Blood-based Cancer Screening Tests Market Size Market Share by Application (2021-2026)
3 BLOOD-BASED CANCER SCREENING TESTS MARKET SIZE BY PLAYER
3.1 Blood-based Cancer Screening Tests Market Size Market Share by Player
3.1.1 Global Blood-based Cancer Screening Tests Revenue by Player (2021-2026)
3.1.2 Global Blood-based Cancer Screening Tests Revenue Market Share by Player (2021-2026)
3.2 Global Blood-based Cancer Screening Tests Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BLOOD-BASED CANCER SCREENING TESTS BY REGION
4.1 Blood-based Cancer Screening Tests Market Size by Region (2021-2026)
4.2 Global Blood-based Cancer Screening Tests Annual Revenue by Country/Region (2021-2026)
4.3 Americas Blood-based Cancer Screening Tests Market Size Growth (2021-2026)
4.4 APAC Blood-based Cancer Screening Tests Market Size Growth (2021-2026)
4.5 Europe Blood-based Cancer Screening Tests Market Size Growth (2021-2026)
4.6 Middle East & Africa Blood-based Cancer Screening Tests Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Blood-based Cancer Screening Tests Market Size by Country (2021-2026)
5.2 Americas Blood-based Cancer Screening Tests Market Size by Type (2021-2026)
5.3 Americas Blood-based Cancer Screening Tests Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blood-based Cancer Screening Tests Market Size by Region (2021-2026)
6.2 APAC Blood-based Cancer Screening Tests Market Size by Type (2021-2026)
6.3 APAC Blood-based Cancer Screening Tests Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Blood-based Cancer Screening Tests Market Size by Country (2021-2026)
7.2 Europe Blood-based Cancer Screening Tests Market Size by Type (2021-2026)
7.3 Europe Blood-based Cancer Screening Tests Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Blood-based Cancer Screening Tests by Region (2021-2026)
8.2 Middle East & Africa Blood-based Cancer Screening Tests Market Size by Type (2021-2026)
8.3 Middle East & Africa Blood-based Cancer Screening Tests Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BLOOD-BASED CANCER SCREENING TESTS MARKET FORECAST
10.1 Global Blood-based Cancer Screening Tests Forecast by Region (2027-2032)
10.1.1 Global Blood-based Cancer Screening Tests Forecast by Region (2027-2032)
10.1.2 Americas Blood-based Cancer Screening Tests Forecast
10.1.3 APAC Blood-based Cancer Screening Tests Forecast
10.1.4 Europe Blood-based Cancer Screening Tests Forecast
10.1.5 Middle East & Africa Blood-based Cancer Screening Tests Forecast
10.2 Americas Blood-based Cancer Screening Tests Forecast by Country (2027-2032)
10.2.1 United States Market Blood-based Cancer Screening Tests Forecast
10.2.2 Canada Market Blood-based Cancer Screening Tests Forecast
10.2.3 Mexico Market Blood-based Cancer Screening Tests Forecast
10.2.4 Brazil Market Blood-based Cancer Screening Tests Forecast
10.3 APAC Blood-based Cancer Screening Tests Forecast by Region (2027-2032)
10.3.1 China Blood-based Cancer Screening Tests Market Forecast
10.3.2 Japan Market Blood-based Cancer Screening Tests Forecast
10.3.3 Korea Market Blood-based Cancer Screening Tests Forecast
10.3.4 Southeast Asia Market Blood-based Cancer Screening Tests Forecast
10.3.5 India Market Blood-based Cancer Screening Tests Forecast
10.3.6 Australia Market Blood-based Cancer Screening Tests Forecast
10.4 Europe Blood-based Cancer Screening Tests Forecast by Country (2027-2032)
10.4.1 Germany Market Blood-based Cancer Screening Tests Forecast
10.4.2 France Market Blood-based Cancer Screening Tests Forecast
10.4.3 UK Market Blood-based Cancer Screening Tests Forecast
10.4.4 Italy Market Blood-based Cancer Screening Tests Forecast
10.4.5 Russia Market Blood-based Cancer Screening Tests Forecast
10.5 Middle East & Africa Blood-based Cancer Screening Tests Forecast by Region (2027-2032)
10.5.1 Egypt Market Blood-based Cancer Screening Tests Forecast
10.5.2 South Africa Market Blood-based Cancer Screening Tests Forecast
10.5.3 Israel Market Blood-based Cancer Screening Tests Forecast
10.5.4 Turkey Market Blood-based Cancer Screening Tests Forecast
10.6 Global Blood-based Cancer Screening Tests Forecast by Type (2027-2032)
10.7 Global Blood-based Cancer Screening Tests Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Blood-based Cancer Screening Tests Forecast
11 KEY PLAYERS ANALYSIS
11.1 GRAIL
11.1.1 GRAIL Company Information
11.1.2 GRAIL Blood-based Cancer Screening Tests Product Offered
11.1.3 GRAIL Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 GRAIL Main Business Overview
11.1.5 GRAIL Latest Developments
11.2 Guardant Health
11.2.1 Guardant Health Company Information
11.2.2 Guardant Health Blood-based Cancer Screening Tests Product Offered
11.2.3 Guardant Health Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Guardant Health Main Business Overview
11.2.5 Guardant Health Latest Developments
11.3 Exact Sciences
11.3.1 Exact Sciences Company Information
11.3.2 Exact Sciences Blood-based Cancer Screening Tests Product Offered
11.3.3 Exact Sciences Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Exact Sciences Main Business Overview
11.3.5 Exact Sciences Latest Developments
11.4 Freenome
11.4.1 Freenome Company Information
11.4.2 Freenome Blood-based Cancer Screening Tests Product Offered
11.4.3 Freenome Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Freenome Main Business Overview
11.4.5 Freenome Latest Developments
11.5 Natera
11.5.1 Natera Company Information
11.5.2 Natera Blood-based Cancer Screening Tests Product Offered
11.5.3 Natera Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Natera Main Business Overview
11.5.5 Natera Latest Developments
11.6 Foresight Diagnostics
11.6.1 Foresight Diagnostics Company Information
11.6.2 Foresight Diagnostics Blood-based Cancer Screening Tests Product Offered
11.6.3 Foresight Diagnostics Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Foresight Diagnostics Main Business Overview
11.6.5 Foresight Diagnostics Latest Developments
11.7 Burning Rock Biotech
11.7.1 Burning Rock Biotech Company Information
11.7.2 Burning Rock Biotech Blood-based Cancer Screening Tests Product Offered
11.7.3 Burning Rock Biotech Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Burning Rock Biotech Main Business Overview
11.7.5 Burning Rock Biotech Latest Developments
11.8 Genetron Health
11.8.1 Genetron Health Company Information
11.8.2 Genetron Health Blood-based Cancer Screening Tests Product Offered
11.8.3 Genetron Health Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Genetron Health Main Business Overview
11.8.5 Genetron Health Latest Developments
11.9 Singlera Genomics
11.9.1 Singlera Genomics Company Information
11.9.2 Singlera Genomics Blood-based Cancer Screening Tests Product Offered
11.9.3 Singlera Genomics Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Singlera Genomics Main Business Overview
11.9.5 Singlera Genomics Latest Developments
11.10 Berry Oncology
11.10.1 Berry Oncology Company Information
11.10.2 Berry Oncology Blood-based Cancer Screening Tests Product Offered
11.10.3 Berry Oncology Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Berry Oncology Main Business Overview
11.10.5 Berry Oncology Latest Developments
11.11 Helio Genomics
11.11.1 Helio Genomics Company Information
11.11.2 Helio Genomics Blood-based Cancer Screening Tests Product Offered
11.11.3 Helio Genomics Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Helio Genomics Main Business Overview
11.11.5 Helio Genomics Latest Developments
11.12 Sysmex
11.12.1 Sysmex Company Information
11.12.2 Sysmex Blood-based Cancer Screening Tests Product Offered
11.12.3 Sysmex Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Sysmex Main Business Overview
11.12.5 Sysmex Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Blood-based Cancer Screening Tests Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Blood-based Cancer Screening Tests Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Single-cancer Screening
Table 4. Major Players of Multi-cancer Early Detection
Table 5. Major Players of Colorectal Cancer Screening
Table 6. Major Players of Liver Cancer Screening
Table 7. Major Players of Lung Cancer Screening
Table 8. Major Players of Risk Stratification Test
Table 9. Major Players of Other
Table 10. Blood-based Cancer Screening Tests Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Blood-based Cancer Screening Tests Market Size by Type (2021-2026) & ($ millions)
Table 12. Global Blood-based Cancer Screening Tests Market Size Market Share by Type (2021-2026)
Table 13. Major Players of cfDNA Methylation
Table 14. Major Players of ctDNA Mutation
Table 15. Major Players of Fragmentomics
Table 16. Major Players of Protein Biomarkers
Table 17. Major Players of Multi-omics
Table 18. Major Players of Exosome-based
Table 19. Major Players of Other
Table 20. Blood-based Cancer Screening Tests Market Size CAGR by Biomarker (2021 VS 2025 VS 2032) & ($ millions)
Table 21. Global Blood-based Cancer Screening Tests Market Size by Biomarker (2021-2026) & ($ millions)
Table 22. Global Blood-based Cancer Screening Tests Market Size Market Share by Biomarker (2021-2026)
Table 23. Major Players of Laboratory-developed Test
Table 24. Major Players of IVD Kit
Table 25. Major Players of Sequencing-based
Table 26. Major Players of PCR-based
Table 27. Major Players of Immunoassay-based
Table 28. Major Players of Other
Table 29. Blood-based Cancer Screening Tests Market Size CAGR by Test Format (2021 VS 2025 VS 2032) & ($ millions)
Table 30. Global Blood-based Cancer Screening Tests Market Size by Test Format (2021-2026) & ($ millions)
Table 31. Global Blood-based Cancer Screening Tests Market Size Market Share by Test Format (2021-2026)
Table 32. Blood-based Cancer Screening Tests Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 33. Global Blood-based Cancer Screening Tests Market Size by Application (2021-2026) & ($ millions)
Table 34. Global Blood-based Cancer Screening Tests Market Size Market Share by Application (2021-2026)
Table 35. Global Blood-based Cancer Screening Tests Revenue by Player (2021-2026) & ($ millions)
Table 36. Global Blood-based Cancer Screening Tests Revenue Market Share by Player (2021-2026)
Table 37. Blood-based Cancer Screening Tests Key Players Head office and Products Offered
Table 38. Blood-based Cancer Screening Tests Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Mergers & Acquisitions, Expansion
Table 41. Global Blood-based Cancer Screening Tests Market Size by Region (2021-2026) & ($ millions)
Table 42. Global Blood-based Cancer Screening Tests Market Size Market Share by Region (2021-2026)
Table 43. Global Blood-based Cancer Screening Tests Revenue by Country/Region (2021-2026) & ($ millions)
Table 44. Global Blood-based Cancer Screening Tests Revenue Market Share by Country/Region (2021-2026)
Table 45. Americas Blood-based Cancer Screening Tests Market Size by Country (2021-2026) & ($ millions)
Table 46. Americas Blood-based Cancer Screening Tests Market Size Market Share by Country (2021-2026)
Table 47. Americas Blood-based Cancer Screening Tests Market Size by Type (2021-2026) & ($ millions)
Table 48. Americas Blood-based Cancer Screening Tests Market Size Market Share by Type (2021-2026)
Table 49. Americas Blood-based Cancer Screening Tests Market Size by Application (2021-2026) & ($ millions)
Table 50. Americas Blood-based Cancer Screening Tests Market Size Market Share by Application (2021-2026)
Table 51. APAC Blood-based Cancer Screening Tests Market Size by Region (2021-2026) & ($ millions)
Table 52. APAC Blood-based Cancer Screening Tests Market Size Market Share by Region (2021-2026)
Table 53. APAC Blood-based Cancer Screening Tests Market Size by Type (2021-2026) & ($ millions)
Table 54. APAC Blood-based Cancer Screening Tests Market Size by Application (2021-2026) & ($ millions)
Table 55. Europe Blood-based Cancer Screening Tests Market Size by Country (2021-2026) & ($ millions)
Table 56. Europe Blood-based Cancer Screening Tests Market Size Market Share by Country (2021-2026)
Table 57. Europe Blood-based Cancer Screening Tests Market Size by Type (2021-2026) & ($ millions)
Table 58. Europe Blood-based Cancer Screening Tests Market Size by Application (2021-2026) & ($ millions)
Table 59. Middle East & Africa Blood-based Cancer Screening Tests Market Size by Region (2021-2026) & ($ millions)
Table 60. Middle East & Africa Blood-based Cancer Screening Tests Market Size by Type (2021-2026) & ($ millions)
Table 61. Middle East & Africa Blood-based Cancer Screening Tests Market Size by Application (2021-2026) & ($ millions)
Table 62. Key Market Drivers & Growth Opportunities of Blood-based Cancer Screening Tests
Table 63. Key Market Challenges & Risks of Blood-based Cancer Screening Tests
Table 64. Key Industry Trends of Blood-based Cancer Screening Tests
Table 65. Global Blood-based Cancer Screening Tests Market Size Forecast by Region (2027-2032) & ($ millions)
Table 66. Global Blood-based Cancer Screening Tests Market Size Market Share Forecast by Region (2027-2032)
Table 67. Global Blood-based Cancer Screening Tests Market Size Forecast by Type (2027-2032) & ($ millions)
Table 68. Global Blood-based Cancer Screening Tests Market Size Forecast by Application (2027-2032) & ($ millions)
Table 69. GRAIL Details, Company Type, Blood-based Cancer Screening Tests Area Served and Its Competitors
Table 70. GRAIL Blood-based Cancer Screening Tests Product Offered
Table 71. GRAIL Blood-based Cancer Screening Tests Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. GRAIL Main Business
Table 73. GRAIL Latest Developments
Table 74. Guardant Health Details, Company Type, Blood-based Cancer Screening Tests Area Served and Its Competitors
Table 75. Guardant Health Blood-based Cancer Screening Tests Product Offered
Table 76. Guardant Health Blood-based Cancer Screening Tests Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. Guardant Health Main Business
Table 78. Guardant Health Latest Developments
Table 79. Exact Sciences Details, Company Type, Blood-based Cancer Screening Tests Area Served and Its Competitors
Table 80. Exact Sciences Blood-based Cancer Screening Tests Product Offered
Table 81. Exact Sciences Blood-based Cancer Screening Tests Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. Exact Sciences Main Business
Table 83. Exact Sciences Latest Developments
Table 84. Freenome Details, Company Type, Blood-based Cancer Screening Tests Area Served and Its Competitors
Table 85. Freenome Blood-based Cancer Screening Tests Product Offered
Table 86. Freenome Blood-based Cancer Screening Tests Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. Freenome Main Business
Table 88. Freenome Latest Developments
Table 89. Natera Details, Company Type, Blood-based Cancer Screening Tests Area Served and Its Competitors
Table 90. Natera Blood-based Cancer Screening Tests Product Offered
Table 91. Natera Blood-based Cancer Screening Tests Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. Natera Main Business
Table 93. Natera Latest Developments
Table 94. Foresight Diagnostics Details, Company Type, Blood-based Cancer Screening Tests Area Served and Its Competitors
Table 95. Foresight Diagnostics Blood-based Cancer Screening Tests Product Offered
Table 96. Foresight Diagnostics Blood-based Cancer Screening Tests Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. Foresight Diagnostics Main Business
Table 98. Foresight Diagnostics Latest Developments
Table 99. Burning Rock Biotech Details, Company Type, Blood-based Cancer Screening Tests Area Served and Its Competitors
Table 100. Burning Rock Biotech Blood-based Cancer Screening Tests Product Offered
Table 101. Burning Rock Biotech Blood-based Cancer Screening Tests Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. Burning Rock Biotech Main Business
Table 103. Burning Rock Biotech Latest Developments
Table 104. Genetron Health Details, Company Type, Blood-based Cancer Screening Tests Area Served and Its Competitors
Table 105. Genetron Health Blood-based Cancer Screening Tests Product Offered
Table 106. Genetron Health Blood-based Cancer Screening Tests Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 107. Genetron Health Main Business
Table 108. Genetron Health Latest Developments
Table 109. Singlera Genomics Details, Company Type, Blood-based Cancer Screening Tests Area Served and Its Competitors
Table 110. Singlera Genomics Blood-based Cancer Screening Tests Product Offered
Table 111. Singlera Genomics Blood-based Cancer Screening Tests Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 112. Singlera Genomics Main Business
Table 113. Singlera Genomics Latest Developments
Table 114. Berry Oncology Details, Company Type, Blood-based Cancer Screening Tests Area Served and Its Competitors
Table 115. Berry Oncology Blood-based Cancer Screening Tests Product Offered
Table 116. Berry Oncology Blood-based Cancer Screening Tests Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 117. Berry Oncology Main Business
Table 118. Berry Oncology Latest Developments
Table 119. Helio Genomics Details, Company Type, Blood-based Cancer Screening Tests Area Served and Its Competitors
Table 120. Helio Genomics Blood-based Cancer Screening Tests Product Offered
Table 121. Helio Genomics Blood-based Cancer Screening Tests Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 122. Helio Genomics Main Business
Table 123. Helio Genomics Latest Developments
Table 124. Sysmex Details, Company Type, Blood-based Cancer Screening Tests Area Served and Its Competitors
Table 125. Sysmex Blood-based Cancer Screening Tests Product Offered
Table 126. Sysmex Blood-based Cancer Screening Tests Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 127. Sysmex Main Business
Table 128. Sysmex Latest Developments
Table 1. Blood-based Cancer Screening Tests Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Blood-based Cancer Screening Tests Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Single-cancer Screening
Table 4. Major Players of Multi-cancer Early Detection
Table 5. Major Players of Colorectal Cancer Screening
Table 6. Major Players of Liver Cancer Screening
Table 7. Major Players of Lung Cancer Screening
Table 8. Major Players of Risk Stratification Test
Table 9. Major Players of Other
Table 10. Blood-based Cancer Screening Tests Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Blood-based Cancer Screening Tests Market Size by Type (2021-2026) & ($ millions)
Table 12. Global Blood-based Cancer Screening Tests Market Size Market Share by Type (2021-2026)
Table 13. Major Players of cfDNA Methylation
Table 14. Major Players of ctDNA Mutation
Table 15. Major Players of Fragmentomics
Table 16. Major Players of Protein Biomarkers
Table 17. Major Players of Multi-omics
Table 18. Major Players of Exosome-based
Table 19. Major Players of Other
Table 20. Blood-based Cancer Screening Tests Market Size CAGR by Biomarker (2021 VS 2025 VS 2032) & ($ millions)
Table 21. Global Blood-based Cancer Screening Tests Market Size by Biomarker (2021-2026) & ($ millions)
Table 22. Global Blood-based Cancer Screening Tests Market Size Market Share by Biomarker (2021-2026)
Table 23. Major Players of Laboratory-developed Test
Table 24. Major Players of IVD Kit
Table 25. Major Players of Sequencing-based
Table 26. Major Players of PCR-based
Table 27. Major Players of Immunoassay-based
Table 28. Major Players of Other
Table 29. Blood-based Cancer Screening Tests Market Size CAGR by Test Format (2021 VS 2025 VS 2032) & ($ millions)
Table 30. Global Blood-based Cancer Screening Tests Market Size by Test Format (2021-2026) & ($ millions)
Table 31. Global Blood-based Cancer Screening Tests Market Size Market Share by Test Format (2021-2026)
Table 32. Blood-based Cancer Screening Tests Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 33. Global Blood-based Cancer Screening Tests Market Size by Application (2021-2026) & ($ millions)
Table 34. Global Blood-based Cancer Screening Tests Market Size Market Share by Application (2021-2026)
Table 35. Global Blood-based Cancer Screening Tests Revenue by Player (2021-2026) & ($ millions)
Table 36. Global Blood-based Cancer Screening Tests Revenue Market Share by Player (2021-2026)
Table 37. Blood-based Cancer Screening Tests Key Players Head office and Products Offered
Table 38. Blood-based Cancer Screening Tests Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Mergers & Acquisitions, Expansion
Table 41. Global Blood-based Cancer Screening Tests Market Size by Region (2021-2026) & ($ millions)
Table 42. Global Blood-based Cancer Screening Tests Market Size Market Share by Region (2021-2026)
Table 43. Global Blood-based Cancer Screening Tests Revenue by Country/Region (2021-2026) & ($ millions)
Table 44. Global Blood-based Cancer Screening Tests Revenue Market Share by Country/Region (2021-2026)
Table 45. Americas Blood-based Cancer Screening Tests Market Size by Country (2021-2026) & ($ millions)
Table 46. Americas Blood-based Cancer Screening Tests Market Size Market Share by Country (2021-2026)
Table 47. Americas Blood-based Cancer Screening Tests Market Size by Type (2021-2026) & ($ millions)
Table 48. Americas Blood-based Cancer Screening Tests Market Size Market Share by Type (2021-2026)
Table 49. Americas Blood-based Cancer Screening Tests Market Size by Application (2021-2026) & ($ millions)
Table 50. Americas Blood-based Cancer Screening Tests Market Size Market Share by Application (2021-2026)
Table 51. APAC Blood-based Cancer Screening Tests Market Size by Region (2021-2026) & ($ millions)
Table 52. APAC Blood-based Cancer Screening Tests Market Size Market Share by Region (2021-2026)
Table 53. APAC Blood-based Cancer Screening Tests Market Size by Type (2021-2026) & ($ millions)
Table 54. APAC Blood-based Cancer Screening Tests Market Size by Application (2021-2026) & ($ millions)
Table 55. Europe Blood-based Cancer Screening Tests Market Size by Country (2021-2026) & ($ millions)
Table 56. Europe Blood-based Cancer Screening Tests Market Size Market Share by Country (2021-2026)
Table 57. Europe Blood-based Cancer Screening Tests Market Size by Type (2021-2026) & ($ millions)
Table 58. Europe Blood-based Cancer Screening Tests Market Size by Application (2021-2026) & ($ millions)
Table 59. Middle East & Africa Blood-based Cancer Screening Tests Market Size by Region (2021-2026) & ($ millions)
Table 60. Middle East & Africa Blood-based Cancer Screening Tests Market Size by Type (2021-2026) & ($ millions)
Table 61. Middle East & Africa Blood-based Cancer Screening Tests Market Size by Application (2021-2026) & ($ millions)
Table 62. Key Market Drivers & Growth Opportunities of Blood-based Cancer Screening Tests
Table 63. Key Market Challenges & Risks of Blood-based Cancer Screening Tests
Table 64. Key Industry Trends of Blood-based Cancer Screening Tests
Table 65. Global Blood-based Cancer Screening Tests Market Size Forecast by Region (2027-2032) & ($ millions)
Table 66. Global Blood-based Cancer Screening Tests Market Size Market Share Forecast by Region (2027-2032)
Table 67. Global Blood-based Cancer Screening Tests Market Size Forecast by Type (2027-2032) & ($ millions)
Table 68. Global Blood-based Cancer Screening Tests Market Size Forecast by Application (2027-2032) & ($ millions)
Table 69. GRAIL Details, Company Type, Blood-based Cancer Screening Tests Area Served and Its Competitors
Table 70. GRAIL Blood-based Cancer Screening Tests Product Offered
Table 71. GRAIL Blood-based Cancer Screening Tests Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. GRAIL Main Business
Table 73. GRAIL Latest Developments
Table 74. Guardant Health Details, Company Type, Blood-based Cancer Screening Tests Area Served and Its Competitors
Table 75. Guardant Health Blood-based Cancer Screening Tests Product Offered
Table 76. Guardant Health Blood-based Cancer Screening Tests Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. Guardant Health Main Business
Table 78. Guardant Health Latest Developments
Table 79. Exact Sciences Details, Company Type, Blood-based Cancer Screening Tests Area Served and Its Competitors
Table 80. Exact Sciences Blood-based Cancer Screening Tests Product Offered
Table 81. Exact Sciences Blood-based Cancer Screening Tests Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. Exact Sciences Main Business
Table 83. Exact Sciences Latest Developments
Table 84. Freenome Details, Company Type, Blood-based Cancer Screening Tests Area Served and Its Competitors
Table 85. Freenome Blood-based Cancer Screening Tests Product Offered
Table 86. Freenome Blood-based Cancer Screening Tests Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. Freenome Main Business
Table 88. Freenome Latest Developments
Table 89. Natera Details, Company Type, Blood-based Cancer Screening Tests Area Served and Its Competitors
Table 90. Natera Blood-based Cancer Screening Tests Product Offered
Table 91. Natera Blood-based Cancer Screening Tests Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. Natera Main Business
Table 93. Natera Latest Developments
Table 94. Foresight Diagnostics Details, Company Type, Blood-based Cancer Screening Tests Area Served and Its Competitors
Table 95. Foresight Diagnostics Blood-based Cancer Screening Tests Product Offered
Table 96. Foresight Diagnostics Blood-based Cancer Screening Tests Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. Foresight Diagnostics Main Business
Table 98. Foresight Diagnostics Latest Developments
Table 99. Burning Rock Biotech Details, Company Type, Blood-based Cancer Screening Tests Area Served and Its Competitors
Table 100. Burning Rock Biotech Blood-based Cancer Screening Tests Product Offered
Table 101. Burning Rock Biotech Blood-based Cancer Screening Tests Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. Burning Rock Biotech Main Business
Table 103. Burning Rock Biotech Latest Developments
Table 104. Genetron Health Details, Company Type, Blood-based Cancer Screening Tests Area Served and Its Competitors
Table 105. Genetron Health Blood-based Cancer Screening Tests Product Offered
Table 106. Genetron Health Blood-based Cancer Screening Tests Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 107. Genetron Health Main Business
Table 108. Genetron Health Latest Developments
Table 109. Singlera Genomics Details, Company Type, Blood-based Cancer Screening Tests Area Served and Its Competitors
Table 110. Singlera Genomics Blood-based Cancer Screening Tests Product Offered
Table 111. Singlera Genomics Blood-based Cancer Screening Tests Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 112. Singlera Genomics Main Business
Table 113. Singlera Genomics Latest Developments
Table 114. Berry Oncology Details, Company Type, Blood-based Cancer Screening Tests Area Served and Its Competitors
Table 115. Berry Oncology Blood-based Cancer Screening Tests Product Offered
Table 116. Berry Oncology Blood-based Cancer Screening Tests Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 117. Berry Oncology Main Business
Table 118. Berry Oncology Latest Developments
Table 119. Helio Genomics Details, Company Type, Blood-based Cancer Screening Tests Area Served and Its Competitors
Table 120. Helio Genomics Blood-based Cancer Screening Tests Product Offered
Table 121. Helio Genomics Blood-based Cancer Screening Tests Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 122. Helio Genomics Main Business
Table 123. Helio Genomics Latest Developments
Table 124. Sysmex Details, Company Type, Blood-based Cancer Screening Tests Area Served and Its Competitors
Table 125. Sysmex Blood-based Cancer Screening Tests Product Offered
Table 126. Sysmex Blood-based Cancer Screening Tests Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 127. Sysmex Main Business
Table 128. Sysmex Latest Developments
LIST OF FIGURES
Figure 1. Blood-based Cancer Screening Tests Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Blood-based Cancer Screening Tests Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Blood-based Cancer Screening Tests Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Blood-based Cancer Screening Tests Sales Market Share by Country/Region (2025)
Figure 8. Blood-based Cancer Screening Tests Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Blood-based Cancer Screening Tests Market Size Market Share by Type in 2025
Figure 10. Global Blood-based Cancer Screening Tests Market Size Market Share by Biomarker in 2025
Figure 11. Global Blood-based Cancer Screening Tests Market Size Market Share by Test Format in 2025
Figure 12. Blood-based Cancer Screening Tests in Health Check-up Centers
Figure 13. Global Blood-based Cancer Screening Tests Market: Health Check-up Centers (2021-2026) & ($ millions)
Figure 14. Blood-based Cancer Screening Tests in Hospitals
Figure 15. Global Blood-based Cancer Screening Tests Market: Hospitals (2021-2026) & ($ millions)
Figure 16. Blood-based Cancer Screening Tests in Independent Clinical Laboratories
Figure 17. Global Blood-based Cancer Screening Tests Market: Independent Clinical Laboratories (2021-2026) & ($ millions)
Figure 18. Blood-based Cancer Screening Tests in Other
Figure 19. Global Blood-based Cancer Screening Tests Market: Other (2021-2026) & ($ millions)
Figure 20. Global Blood-based Cancer Screening Tests Market Size Market Share by Application in 2025
Figure 21. Global Blood-based Cancer Screening Tests Revenue Market Share by Player in 2025
Figure 22. Global Blood-based Cancer Screening Tests Market Size Market Share by Region (2021-2026)
Figure 23. Americas Blood-based Cancer Screening Tests Market Size 2021-2026 ($ millions)
Figure 24. APAC Blood-based Cancer Screening Tests Market Size 2021-2026 ($ millions)
Figure 25. Europe Blood-based Cancer Screening Tests Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Blood-based Cancer Screening Tests Market Size 2021-2026 ($ millions)
Figure 27. Americas Blood-based Cancer Screening Tests Value Market Share by Country in 2025
Figure 28. United States Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Blood-based Cancer Screening Tests Market Size Market Share by Region in 2025
Figure 33. APAC Blood-based Cancer Screening Tests Market Size Market Share by Type (2021-2026)
Figure 34. APAC Blood-based Cancer Screening Tests Market Size Market Share by Application (2021-2026)
Figure 35. China Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 39. India Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Blood-based Cancer Screening Tests Market Size Market Share by Country in 2025
Figure 42. Europe Blood-based Cancer Screening Tests Market Size Market Share by Type (2021-2026)
Figure 43. Europe Blood-based Cancer Screening Tests Market Size Market Share by Application (2021-2026)
Figure 44. Germany Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 45. France Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Blood-based Cancer Screening Tests Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Blood-based Cancer Screening Tests Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Blood-based Cancer Screening Tests Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 58. APAC Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 59. Europe Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 61. United States Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 62. Canada Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 63. Mexico Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 64. Brazil Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 65. China Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 66. Japan Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 67. Korea Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 69. India Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 70. Australia Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 71. Germany Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 72. France Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 73. UK Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 74. Italy Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 75. Russia Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 76. Egypt Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 77. South Africa Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 78. Israel Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 79. Turkey Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 80. Global Blood-based Cancer Screening Tests Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Blood-based Cancer Screening Tests Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 1. Blood-based Cancer Screening Tests Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Blood-based Cancer Screening Tests Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Blood-based Cancer Screening Tests Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Blood-based Cancer Screening Tests Sales Market Share by Country/Region (2025)
Figure 8. Blood-based Cancer Screening Tests Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Blood-based Cancer Screening Tests Market Size Market Share by Type in 2025
Figure 10. Global Blood-based Cancer Screening Tests Market Size Market Share by Biomarker in 2025
Figure 11. Global Blood-based Cancer Screening Tests Market Size Market Share by Test Format in 2025
Figure 12. Blood-based Cancer Screening Tests in Health Check-up Centers
Figure 13. Global Blood-based Cancer Screening Tests Market: Health Check-up Centers (2021-2026) & ($ millions)
Figure 14. Blood-based Cancer Screening Tests in Hospitals
Figure 15. Global Blood-based Cancer Screening Tests Market: Hospitals (2021-2026) & ($ millions)
Figure 16. Blood-based Cancer Screening Tests in Independent Clinical Laboratories
Figure 17. Global Blood-based Cancer Screening Tests Market: Independent Clinical Laboratories (2021-2026) & ($ millions)
Figure 18. Blood-based Cancer Screening Tests in Other
Figure 19. Global Blood-based Cancer Screening Tests Market: Other (2021-2026) & ($ millions)
Figure 20. Global Blood-based Cancer Screening Tests Market Size Market Share by Application in 2025
Figure 21. Global Blood-based Cancer Screening Tests Revenue Market Share by Player in 2025
Figure 22. Global Blood-based Cancer Screening Tests Market Size Market Share by Region (2021-2026)
Figure 23. Americas Blood-based Cancer Screening Tests Market Size 2021-2026 ($ millions)
Figure 24. APAC Blood-based Cancer Screening Tests Market Size 2021-2026 ($ millions)
Figure 25. Europe Blood-based Cancer Screening Tests Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Blood-based Cancer Screening Tests Market Size 2021-2026 ($ millions)
Figure 27. Americas Blood-based Cancer Screening Tests Value Market Share by Country in 2025
Figure 28. United States Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Blood-based Cancer Screening Tests Market Size Market Share by Region in 2025
Figure 33. APAC Blood-based Cancer Screening Tests Market Size Market Share by Type (2021-2026)
Figure 34. APAC Blood-based Cancer Screening Tests Market Size Market Share by Application (2021-2026)
Figure 35. China Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 39. India Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Blood-based Cancer Screening Tests Market Size Market Share by Country in 2025
Figure 42. Europe Blood-based Cancer Screening Tests Market Size Market Share by Type (2021-2026)
Figure 43. Europe Blood-based Cancer Screening Tests Market Size Market Share by Application (2021-2026)
Figure 44. Germany Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 45. France Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Blood-based Cancer Screening Tests Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Blood-based Cancer Screening Tests Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Blood-based Cancer Screening Tests Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Blood-based Cancer Screening Tests Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 58. APAC Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 59. Europe Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 61. United States Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 62. Canada Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 63. Mexico Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 64. Brazil Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 65. China Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 66. Japan Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 67. Korea Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 69. India Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 70. Australia Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 71. Germany Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 72. France Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 73. UK Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 74. Italy Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 75. Russia Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 76. Egypt Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 77. South Africa Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 78. Israel Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 79. Turkey Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
Figure 80. Global Blood-based Cancer Screening Tests Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Blood-based Cancer Screening Tests Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Blood-based Cancer Screening Tests Market Size 2027-2032 ($ millions)
